Aethlon Medical (AEMD) Cash from Investing Activities (2010 - 2026)
Aethlon Medical's (AEMD) quarterly Cash from Investing Activities came in at -$2051.0 in Q1 2026, down 193.57% YoY from $2192.0 in Q1 2025, and down 193.57% quarter-over-quarter from $2192.0 in Q1 2025.
Aethlon Medical (AEMD) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Aethlon Medical's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$2051.0 for Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 193.57% year-over-year to -$2051.0; the trailing twelve-month figure through Mar 2026 stood at -$2051.0 (changed N/A YoY), and the FY2026 full-year result was -$3704.0, changed N/A from the prior year.
- Cash from Investing Activities was -$2051.0 for Q1 2026 at Aethlon Medical, down from $2192.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for AEMD reached as high as $2192.0 in Q1 2025 and fell as low as -$739165.0 in Q3 2022.
- Median Cash from Investing Activities over the past 5 years was -$10048.0 (2023), compared with a mean of -$117368.8.
- Across the five-year window, Cash from Investing Activities tumbled 3944.91% in 2022 and soared 144.67% in 2025, its largest moves.
- Over 5 years, Cash from Investing Activities stood at -$151486.0 in 2022, then surged by 94.19% to -$8807.0 in 2023, then jumped by 75.11% to -$2192.0 in 2024, then surged by 200.0% to $2192.0 in 2025, then tumbled by 193.57% to -$2051.0 in 2026.
- Business Quant data shows AEMD's Cash from Investing Activities at -$2051.0 in Q1 2026, $2192.0 in Q1 2025, and -$2192.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Aethlon Medical | 3.70 Mn | -1.32 Mn | - | -2,051.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,051.00 |
| Mar 31, 2026 | -2,051.00 |
| Mar 31, 2025 | 2,192.00 |
| Mar 31, 2025 | 2,192.00 |
| Dec 31, 2024 | -2,192.00 |
| Dec 31, 2024 | -2,192.00 |
| Mar 31, 2024 | -4,907.00 |
| Mar 31, 2024 | -4,907.00 |
| Dec 31, 2023 | -8,807.00 |
| Dec 31, 2023 | -8,807.00 |
| Sep 30, 2023 | -6,770.00 |
| Sep 30, 2023 | -6,770.00 |
| Jun 30, 2023 | -230,383.00 |
| Jun 30, 2023 | -230,383.00 |
| Mar 31, 2023 | -11,289.00 |
| Mar 31, 2023 | -11,289.00 |
| Dec 31, 2022 | -151,486.00 |
| Dec 31, 2022 | -151,486.00 |
| Sep 30, 2022 | -739,165.00 |
| Sep 30, 2022 | -739,165.00 |